INTRODUCTION
HELLP syndrome is a variant of preeclampsia/eclampsia associated with a high maternal mortality and morbidity. 1 This syndrome was recognised much earlier, it was first described in 1982 by Weinstein. 2 HELLP syndrome is defined as haemolysis, elevated liver enzyme (serum LDH ≥600IU/L, or total bilirubin ≥1.2mg/dl), and low platelet count (≤100000 cells/µl). The incidence is reported approximately 0.1% of all pregnancies, and 10-20% with combined preeclampsia and it occurs normally during the third trimester and progress until delivery. 3 Patients whose pregnancies are complicated by HELLP syndrome are at higher risk of renal failure, consumptive coagulopathy, abruption placentae, pulmonary and cerebral oedema, sub capsular liver haematoma and shock. 4 Diagnosis of the complete form of HELLP syndrome requires the presence of all three major components, while partial or incomplete HELLP syndrome consists of only 1 or 2 elements of the triad (H or El or LP).
The aim of this study is to evaluate the impact of HELLP syndrome on maternal clinical issues with special focus on diagnosis, maternal complications, timing and routes of delivery. Perinatal morbidity and mortality are also outlined.
METHODS
The prospective study was conducted in the department of obstetrics and gynaecology, Burdwan medical college, Burdwan, between January 2012 to December, 2013 on all eclamptic mothers. The Tennessee classification system 6 was used to diagnose complete or partial HELLP syndrome. Complete HELLP syndrome included haemolysis (LDH ≥600IU/L), elevated liver enzymes (SGOT ≥70IU/L) and platelet (≤100000/mm 3 ) and designated as group-B (n=9) in our study. Partial HELLP syndrome (group A, n=45) was diagnosed if the patient presented with one or two of the above criteria. Demographic variables, such as maternal age, parity, gestational age, complaints at admission if patient is conscious, clinical findings, measurement of blood pressure, antihypertensive drug administration, magnesium sulphate and corticosteroid therapy were evaluated. Routine laboratory tests included liver function tests, complete blood count, coagulation profile and renal function tests. Gestational age was determined according to the last menstrual period or first or early second trimester ultrasonography. Different routes of delivery including indications of caesarean section and type of anaesthesia was recorded. APGAR score at 1 and 5 minutes of new born following delivery, birth weight and perinatal outcome were also noted.
Acute renal failure was diagnosed in the presence of oliguria or anuria associated with elevated serum creatinine levels and diminished creatinine clearance. Pulmonary oedema was diagnosed on the basis of clinical finding and chest radiography. Disseminated intravascular coagulation (DIC) was defined as low platelet count (<100000/mm 3 ), low fibrinogen level (300 mg/dl), prolonged prothrombin time (≥14s), partial thromboplastin time (≥40s), and elevated fibrin split products (>40 µg/dl). Intrauterine growth restriction was defined as a birth weight below the 10 th percentile for that gestational age.
All cases above 34 weeks of gestation were delivered promptly. Pregnancies below 34 weeks were terminated after corticosteroid therapy if the maternal condition was unstable and foetal well-being tests were non-reassuring. Blood and blood products were used to correct coagulation abnormalities and anaemia as needed.
Perinatal mortality rate was defined as "number of foetal deaths after 22 weeks of gestation + number of neonatal deaths during the first 29 days/1000 birth".
Statistical analysis was performed using student's t-test and χ2 test where appropriate. All analysis was performed by StatCalc-7 software. All P values <0.05 were considered statistically significant.
RESULTS
Out of 727 cases of eclampsia pt. (incidence 3.91%) 54 cases had HELLP syndrome (incidence 7.43%). HELLP syndrome was diagnosed in the antepartum and postpartum period in 43 (79.63%) and 11 (20.37%) cases respectively. A group of 45 patients were classified as partial or incomplete HELLP (Group A) and a group of 9 patients were classified as complete HELLP syndrome (Group B). Table 1 shows the different clinical variables in 54 women with HELLP syndrome by different groups. The maternal age, parity, gestational age was similar between the two groups of HELLP syndrome. There was a significant difference of systolic (P <0.0146) and diastolic (P <0.0001) blood pressures between the groups of A and B. Table 2 summarizes the laboratory findings in these 54 women with HELLP syndrome by groups. All patients had platelet count below 1 lakh/mm 3 in group B (Mean ± SD, 57888.89 ± 7372.999; range 48000 to 72000/cu.mm).
There were statistically significant differences in platelet counts, LDH and SGOT levels between the groups of A and B of HELLP syndrome. In group B HELLP syndrome, the maximal LDH levels ranged from 1512-2982 IU/L with a mean of 1558.444 IU/L. For group A, the mean was 854.82 IU/L (range 108-1610IU/L). Change of SGPT level varied according to the severity of the disease. The mean peak serum of LDH, SGPT and SGOT were significantly higher in group B when compared to group A with HELLP syndrome (Figure 1 ). Table 3 depicts the maternal outcome. Abruptio placentae (12.96%), acute renal failure (11.11%) and cerebral haemorrhage (11.11%) were most frequent maternal complications followed by DIC (3.70%). Two of the cases of acute renal failure required haemodialysis. 3 . The 54 eclamptic mothers resulted in 59 births (3 sets of twins and one set of triplets). There were fourteen stillbirths and four neonatal deaths for a perinatal rate of 305 per thousand (30.5%).
Comparisons of maternal and foetal morbidity in two groups were enlisted in Table 5 . Acute renal failure, intrauterine growth restriction and intrauterine foetal death were statistically significantly higher in group B (P = 0.020; P = 0.001; P = 0.0001). 
DISCUSSION
In our study the incidence of HELLP syndrome in eclamptic mother was 7.43% where as a high and significant association (36%) between eclampsia and HELLP syndrome was observed by Vigil-De Gracia P, 4 but a weak association between HELLP syndrome and eclampsia was noted by Sibai et al. 7 In our series, most of the HELLP syndrome mothers were nulliparous 90% (49/54) and mean maternal age was 19.944 ± 1.836 years. Patients of our series with HELLP syndrome were 5-6 years younger than those reported by other studies. 2, 4, 7 It is important that HELLP syndrome is a life-threatening complication of pregnancy associated with hypertension with proteinuria. However severe hypertension and proteinuria were not always associated with the syndrome. 4 Thirteen percent (7/54) of patients in the current study had diastolic BP ≤90 mm of Hg, which is comparable to the figure (15%) in other studies. 2, 4, 5, 7 Furthermore, the level of proteinuria was variable: 21 women (38.89%) had proteinuria 3-4+; 28 had 1-2+; and 11.11% had no proteinuria.
In other series, 6 (13.6%) of the patients were normotensive and 7 (15.9%) of them had no proteinuria. 8 So professional care should be taken to all women for HELLP syndrome where hypertension and proteinuria may be absent or slight. In our series 20.38% of patients had postpartum eclampsia, which is in accordance with the report (22.8%) of Yucesoy G et al. 8 Various maternal complications observed in the present study included abruption placenta, acute renal failure, and placental abruption which are already observed in other studies. 9, 10, 12 The overall maternal mortality in our series was 7.40%. The incidence of perinatal mortality was 305/1000 (30.5%). The high perinatal mortality is mainly due to delayed referral of patients in the tertiary centre. Perinatal morbidity and mortality cases are still high in HELLP syndrome cases. 4, 8 The current study also demonstrated that the complete HELLP syndrome has an increased risk of maternal outcome.
The vaginal route of delivery is usually recommended to reduce the risk of surgical stress and bleeding during caesarean section. In our series the rate of caesarean section was lower (27.78%) when compared to other studies. 4, 11 Epidural anaesthesia is contraindicated in HELLP patients due to risk of developing epidural or subdural haematoma or bleeding. 12 Eleven patients (73.33%) in the current study received epidural anaesthesia without any complication during the procedure. Similar finding was also noted by Vigil-De Gracia P. 4 
CONCLUSION
The incidence of HELLP syndrome is 7.43% in pregnancies complicated by eclampsia. Placental abruption, acute renal failure and DIC complicate pregnancies with HELLP syndrome. Perinatal outcome is also adversely affected and mortality rate is 30.5%. To avoid any subsequent complications and to improve the maternal and perinatal outcomes early diagnosis, appropriate and immediate interventions are needed in a tertiary care centre.
